Dopamine transporter mRNA content in human substantia nigra decreases precipitously with age.
Identifieur interne : 001F57 ( Main/Merge ); précédent : 001F56; suivant : 001F58Dopamine transporter mRNA content in human substantia nigra decreases precipitously with age.
Auteurs : M Bannon ; M Poosch ; Y. Xia ; D Goebel ; B. Cassin ; G. KapatosSource :
- Proceedings of the National Academy of Sciences of the United States of America [ 0027-8424 ] ; 1992.
Abstract
The dopamine transporter is the primary means of inactivating synaptic dopamine as well as a major site of action for psychostimulants (such as cocaine and amphetamine) and for neurotoxins that induce parkinsonism. In the present study, a human dopamine transporter partial cDNA clone obtained by polymerase chain reaction exhibited 87% and 89% identity at the nucleic acid and amino acid levels, respectively, with transmembrane domains 3-5 of the rat homolog. This clone was used to quantitate human dopamine transporter mRNA by nuclease protection assay. The postmortem content of dopamine transporter mRNA in the substantia nigrae of 18- to 57-yr-old subjects was relatively constant, while in subjects greater than 57 yr old, a precipitous (greater than 95%) decline in substantia nigra dopamine transporter mRNA was evident. In contrast, tyrosine hydroxylase mRNA in the same samples declined in a linear manner with increasing age. In situ hybridization experiments confirmed the profound loss of dopamine transporter gene expression in melanin-positive (presumptive dopamine) nigral neurons. These data may begin to shed light on compensatory changes occurring in human dopamine neurons during normal aging.
Url:
PubMed: 1353885
PubMed Central: 49652
Links toward previous steps (curation, corpus...)
- to stream Pmc, to step Corpus: 000100
- to stream Pmc, to step Curation: 000100
- to stream Pmc, to step Checkpoint: 000307
- to stream Ncbi, to step Merge: 000064
- to stream Ncbi, to step Curation: 000064
- to stream Ncbi, to step Checkpoint: 000064
Links to Exploration step
PMC:49652Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Dopamine transporter mRNA content in human substantia nigra decreases precipitously with age.</title>
<author><name sortKey="Bannon, M J" sort="Bannon, M J" uniqKey="Bannon M" first="M" last="Bannon">M Bannon</name>
</author>
<author><name sortKey="Poosch, M S" sort="Poosch, M S" uniqKey="Poosch M" first="M" last="Poosch">M Poosch</name>
</author>
<author><name sortKey="Xia, Y" sort="Xia, Y" uniqKey="Xia Y" first="Y" last="Xia">Y. Xia</name>
</author>
<author><name sortKey="Goebel, D J" sort="Goebel, D J" uniqKey="Goebel D" first="D" last="Goebel">D Goebel</name>
</author>
<author><name sortKey="Cassin, B" sort="Cassin, B" uniqKey="Cassin B" first="B" last="Cassin">B. Cassin</name>
</author>
<author><name sortKey="Kapatos, G" sort="Kapatos, G" uniqKey="Kapatos G" first="G" last="Kapatos">G. Kapatos</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PMC</idno>
<idno type="pmid">1353885</idno>
<idno type="pmc">49652</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC49652</idno>
<idno type="RBID">PMC:49652</idno>
<date when="1992">1992</date>
<idno type="wicri:Area/Pmc/Corpus">000100</idno>
<idno type="wicri:Area/Pmc/Curation">000100</idno>
<idno type="wicri:Area/Pmc/Checkpoint">000307</idno>
<idno type="wicri:Area/Ncbi/Merge">000064</idno>
<idno type="wicri:Area/Ncbi/Curation">000064</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000064</idno>
<idno type="wicri:doubleKey">0027-8424:1992:Bannon M:dopamine:transporter:mrna</idno>
<idno type="wicri:Area/Main/Merge">001F57</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Dopamine transporter mRNA content in human substantia nigra decreases precipitously with age.</title>
<author><name sortKey="Bannon, M J" sort="Bannon, M J" uniqKey="Bannon M" first="M" last="Bannon">M Bannon</name>
</author>
<author><name sortKey="Poosch, M S" sort="Poosch, M S" uniqKey="Poosch M" first="M" last="Poosch">M Poosch</name>
</author>
<author><name sortKey="Xia, Y" sort="Xia, Y" uniqKey="Xia Y" first="Y" last="Xia">Y. Xia</name>
</author>
<author><name sortKey="Goebel, D J" sort="Goebel, D J" uniqKey="Goebel D" first="D" last="Goebel">D Goebel</name>
</author>
<author><name sortKey="Cassin, B" sort="Cassin, B" uniqKey="Cassin B" first="B" last="Cassin">B. Cassin</name>
</author>
<author><name sortKey="Kapatos, G" sort="Kapatos, G" uniqKey="Kapatos G" first="G" last="Kapatos">G. Kapatos</name>
</author>
</analytic>
<series><title level="j">Proceedings of the National Academy of Sciences of the United States of America</title>
<idno type="ISSN">0027-8424</idno>
<idno type="e-ISSN">1091-6490</idno>
<imprint><date when="1992">1992</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><p>The dopamine transporter is the primary means of inactivating synaptic dopamine as well as a major site of action for psychostimulants (such as cocaine and amphetamine) and for neurotoxins that induce parkinsonism. In the present study, a human dopamine transporter partial cDNA clone obtained by polymerase chain reaction exhibited 87% and 89% identity at the nucleic acid and amino acid levels, respectively, with transmembrane domains 3-5 of the rat homolog. This clone was used to quantitate human dopamine transporter mRNA by nuclease protection assay. The postmortem content of dopamine transporter mRNA in the substantia nigrae of 18- to 57-yr-old subjects was relatively constant, while in subjects greater than 57 yr old, a precipitous (greater than 95%) decline in substantia nigra dopamine transporter mRNA was evident. In contrast, tyrosine hydroxylase mRNA in the same samples declined in a linear manner with increasing age. In situ hybridization experiments confirmed the profound loss of dopamine transporter gene expression in melanin-positive (presumptive dopamine) nigral neurons. These data may begin to shed light on compensatory changes occurring in human dopamine neurons during normal aging.</p>
<sec sec-type="scanned-figures"><title>Images</title>
<fig id="F1"><graphic xlink:href="pnas01089-0443-a" xlink:role="7096"></graphic>
</fig>
<fig id="F2"><graphic xlink:href="pnas01089-0445-a" xlink:role="7098"></graphic>
</fig>
</sec>
</div>
</front>
</TEI>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/JankovicV1/Data/Main/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001F57 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Merge/biblio.hfd -nk 001F57 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= JankovicV1 |flux= Main |étape= Merge |type= RBID |clé= PMC:49652 |texte= Dopamine transporter mRNA content in human substantia nigra decreases precipitously with age. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Merge/RBID.i -Sk "pubmed:1353885" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Merge/biblio.hfd \ | NlmPubMed2Wicri -a JankovicV1
![]() | This area was generated with Dilib version V0.6.19. | ![]() |